ArticleScientific reports2025
Quantitative analysis of psoriatic nail disease using optical coherence tomography.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantitative Imaging Biomarkers of PRP-Induced Tendon Remodelling in Chronic Tendinopathy: Review and Single-Centre Experience with Ultrasound Radiomics and MRI T2 Profiling.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the clinical utility of optical coherence tomography (OCT) in the assessment of psoriatic nail disease, focusing on its ability to detect early structural changes, quantify lesion severity, and monitor treatment outcomes. Patients with psoriasis (PsO) or psoriatic arthritis (PsA) presenting with nail involvement were enrolled between May 2022 and September 2023. A swept-source OCT system ([Formula: see text], 5 mm depth) was used to image all fingernails. Cross-sectional nail structures were analyzed, and grayscale values were quantified to assess nail integrity. Paired-sample t-tests were applied to compare grayscale values before and after disease progression or treatment ([Formula: see text]). OCT imaging revealed structural abnormalities such as nail plate separation, thinning, depressions, and low-reflectivity regions that were not visible to the naked eye. During disease progression, grayscale values significantly decreased, reflecting loss of nail integrity. Following 4 months of treatment, grayscale values increased by 6-10 units, indicating recovery of nail structure. OCT provided objective measurements that correlated with clinical improvement and offered greater sensitivity than visual inspection. OCT is a non-invasive, high-resolution imaging technique that enables early detection and quantitative monitoring of psoriatic nail disease. Grayscale analysis provides an objective metric for evaluating disease severity and treatment response, supporting OCT as a valuable tool for diagnosis, follow-up, and clinical decision-making in PsO and PsA patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.